Parkinson's Disease

Parkinson’s disease is classed as a neurodegenerative disease of the central nervous system, affecting 6 million people worldwide, most of whom are over 60. Most famously, actor Michael J. Fox deals with this condition.

How does hemp extract help? One of the key roles of the ECS is to regulate the lifespan of a cell, especially in the central nervous system. In neurodegenerative diseases, the ECS has a neuroprotective effect and helps to mitigate the neuronal damage occurring in Parkinson’s.

While current Parkinson’s medication seeks to redress the depletion of dopamine, the main focus of current cannabinoid research is into the neuroprotective, antioxidant and anti-inflammatory properties of Hemp Extract.

Start Shopping Now!

Hemp Extract scavenges the free radicals that are associated with Parkinson’s.

Hemp Extract improves cell survival and the expression of proteins related to growth of neuronal cell parts. It prevents toxin-induced decline of nerve growth factor, which may help in neuron regeneration.

Hemp Extract is also effective in reducing inappropriate muscle tension, which is another symptom of Parkinson’s disease.

Since Parkinson’s disease is difficult to treat, Hemp Extract shows great promise as part of a more comprehensive protocol.

----------

Thank you for taking your time to become educated on the science and technologies behind the best health supplements.

Start Shopping Now!

My best wishes for your best health.

Frank Davis,
Founder and CEO of Optivida Health


[For more science-based evidence for the use of hemp extract read "Hemp Health Revolution: The A to Z Health Benefits of Hemp Extract"] 

Sources

*J Psychopharmacol. 2014 Nov;28(11):1088-98. doi: 10.1177/0269881114550355. Epub 2014 Sep 18.
Effects of cannabidiol in the treatment of patients with Parkinson’s disease: an exploratory double-blind trial.

*Br J Pharmacol. 2011 Aug;163(7):1365-78. doi: 10.1111/j. 1476-5381.2011.01365.x.Prospects for cannabinoid therapies in basal ganglia disorders.

*Brain Res. 2007 Feb 23;1134(1):162-70. Epub 2006 Dec 28. Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson’s disease: importance of antioxidant and cannabinoid receptor-independent properties.


←  Back to News